Leveraging our cross-functional experience in science and finance, we offer services in: technology evaluation, intellectual property strategy, market and financial projections, asset and securities valuation, deal structuring and negotiation. We provide transactional support to biotechnology seed funds, venture capital funds, angel investor groups, biotech companies, and research institutions.
We create value by clarifying opportunities at the early-stage where risks are complex and returns are highest.
